Production and purification of gallium-66 for preparation of tumor-targeting radiopharmaceuticals.

[1]  G. Slegers,et al.  Production of carrier-free66Ga and labeling of antimyosin antibody for positron imaging of acute myocardial infarction , 2004, European Journal of Nuclear Medicine.

[2]  S. Larson,et al.  Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors. , 2002, Nuclear medicine and biology.

[3]  R Laforest,et al.  64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  P. Beaumier,et al.  Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[5]  P. Cutler,et al.  Radiotherapy and dosimetry of 64Cu-TETA-Tyr3-octreotate in a somatostatin receptor-positive, tumor-bearing rat model. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  J. Lewis,et al.  Comparison of four 64Cu-labeled somatostatin analogues in vitro and in a tumor-bearing rat model: evaluation of new derivatives for positron emission tomography imaging and targeted radiotherapy. , 1999, Journal of medicinal chemistry.

[7]  P. Cutler,et al.  Radiotherapy, toxicity and dosimetry of copper-64-TETA-octreotide in tumor-bearing rats. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  J. Powe,et al.  Fluorine-18-fluorodeoxyglucose uptake in rheumatoid arthritis-associated lung disease in a patient with thyroid cancer. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  S. Larson,et al.  An investigation of the physical characteristics of 66Ga as an isotope for PET imaging and quantification. , 1997, Medical physics.

[10]  M J Welch,et al.  Efficient production of high specific activity 64Cu using a biomedical cyclotron. , 1997, Nuclear medicine and biology.

[11]  M. Welch,et al.  Radioimmunotherapy with a 64Cu-labeled monoclonal antibody: a comparison with 67Cu. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Plitnikas,et al.  COMPILATION OF CROSS SECTIONS/THICK TARGET YIELDS FOR 66GA, 67GA AND 68GA PRODUCTION USING ZN TARGETS UP TO 30 MEV PROTON ENERGY , 1994 .

[13]  Z. Kovács,et al.  Excitation Functions of Proton Induced Nuclear Reactions on Enriched 66Zn,67Zn and 68Zn , 1990 .

[14]  Y. Nagame,et al.  Production of 67Ga by alpha bombardment of natural zinc , 1978 .

[15]  A. P. Callahan,et al.  High-yield zinc-68 cyclotron targets for carrier-free gallium-67 production , 1973 .

[16]  J. Dahl,et al.  The use of a compact, multi-particle cyclotron for the production of 52 Fe, 67 Ga, 111 In and 123 I for medical purposes. , 1972, The International journal of applied radiation and isotopes.

[17]  L. Brown.  Chemical processing of cyclotron- produced 67Ga , 1971 .